The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drugs for External Use Market Research Report 2024
Synopsis
Drugs that are used on the body surface or on certain mucous membranes to kill insects and relieve itching, reduce swelling and dissipate stagnation, dissipate putrefaction and discharge pus, promote muscle growth and mouth opening, and astringe and stop bleeding are called external medicines.
Global Drugs for External Use market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drugs for External Use market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drugs for External Use market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Yunnan Baiyao
Linrui
Cheezheng
Shengyang Hongyao
Yulin
Huahong Pharma
LKF
Hubiao
GSK
Tianhe
Wantong Group
Hisamitsu
MUHI
JNJ
Segment by Type
Lotion
Ointment
Tincture
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Drugs for External Use report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Drugs that are used on the body surface or on certain mucous membranes to kill insects and relieve itching, reduce swelling and dissipate stagnation, dissipate putrefaction and discharge pus, promote muscle growth and mouth opening, and astringe and stop bleeding are called external medicines.
Global Drugs for External Use market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drugs for External Use market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drugs for External Use market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Yunnan Baiyao
Linrui
Cheezheng
Shengyang Hongyao
Yulin
Huahong Pharma
LKF
Hubiao
GSK
Tianhe
Wantong Group
Hisamitsu
MUHI
JNJ
Segment by Type
Lotion
Ointment
Tincture
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Drugs for External Use report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Drugs for External Use Market Overview
1.1 Product Overview and Scope of Drugs for External Use
1.2 Drugs for External Use Segment by Type
1.2.1 Global Drugs for External Use Market Value Comparison by Type (2023-2029)
1.2.2 Lotion
1.2.3 Ointment
1.2.4 Tincture
1.2.5 Other
1.3 Drugs for External Use Segment by Application
1.3.1 Global Drugs for External Use Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drugs for External Use Market Size Estimates and Forecasts
1.4.1 Global Drugs for External Use Revenue 2018-2029
1.4.2 Global Drugs for External Use Sales 2018-2029
1.4.3 Global Drugs for External Use Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Drugs for External Use Market Competition by Manufacturers
2.1 Global Drugs for External Use Sales Market Share by Manufacturers (2018-2023)
2.2 Global Drugs for External Use Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Drugs for External Use Average Price by Manufacturers (2018-2023)
2.4 Global Drugs for External Use Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Drugs for External Use, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs for External Use, Product Type & Application
2.7 Drugs for External Use Market Competitive Situation and Trends
2.7.1 Drugs for External Use Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drugs for External Use Players Market Share by Revenue
2.7.3 Global Drugs for External Use Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drugs for External Use Retrospective Market Scenario by Region
3.1 Global Drugs for External Use Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Drugs for External Use Global Drugs for External Use Sales by Region: 2018-2029
3.2.1 Global Drugs for External Use Sales by Region: 2018-2023
3.2.2 Global Drugs for External Use Sales by Region: 2024-2029
3.3 Global Drugs for External Use Global Drugs for External Use Revenue by Region: 2018-2029
3.3.1 Global Drugs for External Use Revenue by Region: 2018-2023
3.3.2 Global Drugs for External Use Revenue by Region: 2024-2029
3.4 North America Drugs for External Use Market Facts & Figures by Country
3.4.1 North America Drugs for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Drugs for External Use Sales by Country (2018-2029)
3.4.3 North America Drugs for External Use Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drugs for External Use Market Facts & Figures by Country
3.5.1 Europe Drugs for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Drugs for External Use Sales by Country (2018-2029)
3.5.3 Europe Drugs for External Use Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for External Use Market Facts & Figures by Country
3.6.1 Asia Pacific Drugs for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Drugs for External Use Sales by Country (2018-2029)
3.6.3 Asia Pacific Drugs for External Use Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drugs for External Use Market Facts & Figures by Country
3.7.1 Latin America Drugs for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Drugs for External Use Sales by Country (2018-2029)
3.7.3 Latin America Drugs for External Use Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for External Use Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Drugs for External Use Sales by Country (2018-2029)
3.8.3 Middle East and Africa Drugs for External Use Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs for External Use Sales by Type (2018-2029)
4.1.1 Global Drugs for External Use Sales by Type (2018-2023)
4.1.2 Global Drugs for External Use Sales by Type (2024-2029)
4.1.3 Global Drugs for External Use Sales Market Share by Type (2018-2029)
4.2 Global Drugs for External Use Revenue by Type (2018-2029)
4.2.1 Global Drugs for External Use Revenue by Type (2018-2023)
4.2.2 Global Drugs for External Use Revenue by Type (2024-2029)
4.2.3 Global Drugs for External Use Revenue Market Share by Type (2018-2029)
4.3 Global Drugs for External Use Price by Type (2018-2029)
5 Segment by Application
5.1 Global Drugs for External Use Sales by Application (2018-2029)
5.1.1 Global Drugs for External Use Sales by Application (2018-2023)
5.1.2 Global Drugs for External Use Sales by Application (2024-2029)
5.1.3 Global Drugs for External Use Sales Market Share by Application (2018-2029)
5.2 Global Drugs for External Use Revenue by Application (2018-2029)
5.2.1 Global Drugs for External Use Revenue by Application (2018-2023)
5.2.2 Global Drugs for External Use Revenue by Application (2024-2029)
5.2.3 Global Drugs for External Use Revenue Market Share by Application (2018-2029)
5.3 Global Drugs for External Use Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Yunnan Baiyao
6.1.1 Yunnan Baiyao Corporation Information
6.1.2 Yunnan Baiyao Description and Business Overview
6.1.3 Yunnan Baiyao Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Yunnan Baiyao Drugs for External Use Product Portfolio
6.1.5 Yunnan Baiyao Recent Developments/Updates
6.2 Linrui
6.2.1 Linrui Corporation Information
6.2.2 Linrui Description and Business Overview
6.2.3 Linrui Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Linrui Drugs for External Use Product Portfolio
6.2.5 Linrui Recent Developments/Updates
6.3 Cheezheng
6.3.1 Cheezheng Corporation Information
6.3.2 Cheezheng Description and Business Overview
6.3.3 Cheezheng Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cheezheng Drugs for External Use Product Portfolio
6.3.5 Cheezheng Recent Developments/Updates
6.4 Shengyang Hongyao
6.4.1 Shengyang Hongyao Corporation Information
6.4.2 Shengyang Hongyao Description and Business Overview
6.4.3 Shengyang Hongyao Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shengyang Hongyao Drugs for External Use Product Portfolio
6.4.5 Shengyang Hongyao Recent Developments/Updates
6.5 Yulin
6.5.1 Yulin Corporation Information
6.5.2 Yulin Description and Business Overview
6.5.3 Yulin Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Yulin Drugs for External Use Product Portfolio
6.5.5 Yulin Recent Developments/Updates
6.6 Huahong Pharma
6.6.1 Huahong Pharma Corporation Information
6.6.2 Huahong Pharma Description and Business Overview
6.6.3 Huahong Pharma Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Huahong Pharma Drugs for External Use Product Portfolio
6.6.5 Huahong Pharma Recent Developments/Updates
6.7 LKF
6.6.1 LKF Corporation Information
6.6.2 LKF Description and Business Overview
6.6.3 LKF Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LKF Drugs for External Use Product Portfolio
6.7.5 LKF Recent Developments/Updates
6.8 Hubiao
6.8.1 Hubiao Corporation Information
6.8.2 Hubiao Description and Business Overview
6.8.3 Hubiao Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hubiao Drugs for External Use Product Portfolio
6.8.5 Hubiao Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GSK Drugs for External Use Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Tianhe
6.10.1 Tianhe Corporation Information
6.10.2 Tianhe Description and Business Overview
6.10.3 Tianhe Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Tianhe Drugs for External Use Product Portfolio
6.10.5 Tianhe Recent Developments/Updates
6.11 Wantong Group
6.11.1 Wantong Group Corporation Information
6.11.2 Wantong Group Drugs for External Use Description and Business Overview
6.11.3 Wantong Group Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Wantong Group Drugs for External Use Product Portfolio
6.11.5 Wantong Group Recent Developments/Updates
6.12 Hisamitsu
6.12.1 Hisamitsu Corporation Information
6.12.2 Hisamitsu Drugs for External Use Description and Business Overview
6.12.3 Hisamitsu Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hisamitsu Drugs for External Use Product Portfolio
6.12.5 Hisamitsu Recent Developments/Updates
6.13 MUHI
6.13.1 MUHI Corporation Information
6.13.2 MUHI Drugs for External Use Description and Business Overview
6.13.3 MUHI Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.13.4 MUHI Drugs for External Use Product Portfolio
6.13.5 MUHI Recent Developments/Updates
6.14 JNJ
6.14.1 JNJ Corporation Information
6.14.2 JNJ Drugs for External Use Description and Business Overview
6.14.3 JNJ Drugs for External Use Sales, Revenue and Gross Margin (2018-2023)
6.14.4 JNJ Drugs for External Use Product Portfolio
6.14.5 JNJ Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for External Use Industry Chain Analysis
7.2 Drugs for External Use Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for External Use Production Mode & Process
7.4 Drugs for External Use Sales and Marketing
7.4.1 Drugs for External Use Sales Channels
7.4.2 Drugs for External Use Distributors
7.5 Drugs for External Use Customers
8 Drugs for External Use Market Dynamics
8.1 Drugs for External Use Industry Trends
8.2 Drugs for External Use Market Drivers
8.3 Drugs for External Use Market Challenges
8.4 Drugs for External Use Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
